APA (7th ed.) Citation

MP, S., MHD, v. B., MG, H., N, H., HC, v. D., JHM, K., . . . RPMG, H. (2021). Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy. Gynecologic oncology, 163(2), 371. https://doi.org/10.1016/j.ygyno.2021.08.019

Chicago Style (17th ed.) Citation

MP, Steenbeek, et al. "Evaluation of a Patient Decision Aid for BRCA1/2 Pathogenic Variant Carriers Choosing an Ovarian Cancer Prevention Strategy." Gynecologic Oncology 163, no. 2 (2021): 371. https://doi.org/10.1016/j.ygyno.2021.08.019.

MLA (9th ed.) Citation

MP, Steenbeek, et al. "Evaluation of a Patient Decision Aid for BRCA1/2 Pathogenic Variant Carriers Choosing an Ovarian Cancer Prevention Strategy." Gynecologic Oncology, vol. 163, no. 2, 2021, p. 371, https://doi.org/10.1016/j.ygyno.2021.08.019.